Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
15
CHYM Quote, Financials, Valuation and Earnings
Last price:
$31.48
Seasonality move
:
--
Day range:
$29.85 - $31.75
52-week range:
$28.21 - $44.94
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
1.9M
Avg. volume:
--
1-year change:
--
Market cap:
$11.5B
Revenue:
$1.7B
EPS (TTM):
--
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | $1B | $1.3B | $1.7B | |
| Revenue Growth (YoY) | -- | -- | -- | 26.73% | 30.88% | |
| Cost of Revenues | -- | -- | $214.7M | $219.7M | $207.5M | |
| Gross Profit | -- | -- | $794.2M | $1.1B | $1.5B | |
| Gross Profit Margin | -- | -- | 78.72% | 82.81% | 87.6% | |
| R&D Expenses | -- | -- | $242.4M | $259M | $309.6M | |
| Selling, General & Admin | -- | -- | $603.9M | $598.8M | $697M | |
| Other Inc / (Exp) | -- | -- | $8.1M | $32.8M | $39.5M | |
| Operating Expenses | -- | -- | $1.3B | $1.3B | $1.5B | |
| Operating Income | -- | -- | -$478.7M | -$235.8M | -$62.2M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -- | -$470.6M | -$203M | -$22.7M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -$337K | $234K | $2.6M | |
| Net Income to Company | -- | -- | -$470.3M | -$203.2M | -$25.3M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -$470.3M | -$203.2M | -$25.3M | |
| Basic EPS (Cont. Ops) | -- | -- | -$1.41 | -$0.61 | -$2.33 | |
| Diluted EPS (Cont. Ops) | -- | -- | -$1.41 | -$0.61 | -$2.33 | |
| Weighted Average Basic Share | -- | -- | $336.4M | $336.4M | $333M | |
| Weighted Average Diluted Share | -- | -- | $336.4M | $336.4M | $333M | |
| EBITDA | -- | -- | -$471.4M | -$222.8M | -$36.8M | |
| EBIT | -- | -- | -$478.7M | -$235.8M | -$62.2M | |
| Revenue (Reported) | -- | -- | $1B | $1.3B | $1.7B | |
| Operating Income (Reported) | -- | -- | -$478.7M | -$235.8M | -$62.2M | |
| Operating Income (Adjusted) | -- | -- | -$478.7M | -$235.8M | -$62.2M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | $392M | $518.7M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | $47.4M | $60.4M | |
| Gross Profit | -- | -- | -- | $344.5M | $458.3M | |
| Gross Profit Margin | -- | -- | -- | 87.9% | 88.35% | |
| R&D Expenses | -- | -- | -- | $74.9M | $77.9M | |
| Selling, General & Admin | -- | -- | -- | $156.3M | $179.7M | |
| Other Inc / (Exp) | -- | -- | -- | $10.5M | $5.4M | |
| Operating Expenses | -- | -- | -- | $339.5M | $449.2M | |
| Operating Income | -- | -- | -- | $5M | $9.1M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -- | -- | $15.5M | $14.5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -$362K | $1.6M | |
| Net Income to Company | -- | -- | -- | $15.9M | $12.9M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -- | $15.9M | $12.9M | |
| Basic EPS (Cont. Ops) | -- | -- | -- | -- | -$0.10 | |
| Diluted EPS (Cont. Ops) | -- | -- | -- | -- | -$0.10 | |
| Weighted Average Basic Share | -- | -- | -- | $336.4M | $336.4M | |
| Weighted Average Diluted Share | -- | -- | -- | $336.4M | $336.4M | |
| EBITDA | -- | -- | -- | $10.3M | $16.4M | |
| EBIT | -- | -- | -- | $5M | $9.1M | |
| Revenue (Reported) | -- | -- | -- | $392M | $518.7M | |
| Operating Income (Reported) | -- | -- | -- | $5M | $9.1M | |
| Operating Income (Adjusted) | -- | -- | -- | $5M | $9.1M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | $10.5M | $15.9M | |
| Operating Expenses | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -- | -- | -- | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -- | -- | -- | |
| Basic EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
| Diluted EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | -- | -- | -- | -- | -- | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | -- | -- | -- | -- | -- | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | $392M | $518.7M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | $47.4M | $60.4M | |
| Gross Profit | -- | -- | -- | $344.5M | $458.3M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | $74.9M | $77.9M | |
| Selling, General & Admin | -- | -- | -- | $156.3M | $179.7M | |
| Other Inc / (Exp) | -- | -- | -- | $10.5M | $5.4M | |
| Operating Expenses | -- | -- | -- | $339.5M | $449.2M | |
| Operating Income | -- | -- | -- | $5M | $9.1M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -- | -- | $15.5M | $14.5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -$362K | $1.6M | |
| Net Income to Company | -- | -- | -- | $15.9M | $12.9M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -- | $15.9M | $12.9M | |
| Basic EPS (Cont. Ops) | -- | -- | -- | -- | -$0.10 | |
| Diluted EPS (Cont. Ops) | -- | -- | -- | -- | -$0.10 | |
| Weighted Average Basic Share | -- | -- | -- | $336.4M | $336.4M | |
| Weighted Average Diluted Share | -- | -- | -- | $336.4M | $336.4M | |
| EBITDA | -- | -- | -- | $10.3M | $16.4M | |
| EBIT | -- | -- | -- | $5M | $9.1M | |
| Revenue (Reported) | -- | -- | -- | $392M | $518.7M | |
| Operating Income (Reported) | -- | -- | -- | $5M | $9.1M | |
| Operating Income (Adjusted) | -- | -- | -- | $5M | $9.1M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | -- | $203.4M | $239.7M | $337.7M | |
| Short Term Investments | -- | -- | $734.6M | $560.9M | $368.9M | |
| Accounts Receivable, Net | -- | -- | $123.2M | $176.5M | $216.2M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | $58.1M | $46M | $70.5M | |
| Total Current Assets | -- | -- | $1.3B | $1.2B | $1.3B | |
| Property Plant And Equipment | -- | -- | $146.2M | $157.5M | $142M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | $200K | $914K | $32M | |
| Total Assets | -- | -- | $1.4B | $1.3B | $1.5B | |
| Accounts Payable | -- | -- | $20.8M | $22.1M | $35.8M | |
| Accrued Expenses | -- | -- | $68.9M | $99.3M | $108.2M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | $6.3M | $12M | $15.7M | |
| Other Current Liabilities | -- | -- | $101.8M | $108.4M | $161.6M | |
| Total Current Liabilities | -- | -- | $215.5M | $288.7M | $374.8M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | -- | $316.7M | $383.7M | $501.5M | |
| Common Stock | -- | -- | $2.9B | $2.9B | $2.9B | |
| Other Common Equity Adj | -- | -- | -$6.8M | $720K | $203K | |
| Common Equity | -- | -- | -$1.8B | -$2B | -$1.9B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -- | -- | $1.1B | $936.5M | $959.5M | |
| Total Liabilities and Equity | -- | -- | $1.4B | $1.3B | $1.5B | |
| Cash and Short Terms | -- | -- | $938M | $800.6M | $706.6M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | -- | -- | -- | $318.2M | |
| Short Term Investments | -- | -- | -- | -- | $336.5M | |
| Accounts Receivable, Net | -- | -- | -- | -- | $241.7M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | $79.2M | |
| Total Current Assets | -- | -- | -- | -- | $1.3B | |
| Property Plant And Equipment | -- | -- | -- | -- | $137.8M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | $32.4M | |
| Total Assets | -- | -- | -- | -- | $1.4B | |
| Accounts Payable | -- | -- | -- | -- | $37.6M | |
| Accrued Expenses | -- | -- | -- | -- | $100M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | $14.3M | |
| Other Current Liabilities | -- | -- | -- | -- | $167.8M | |
| Total Current Liabilities | -- | -- | -- | -- | $333.5M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | -- | -- | -- | $454M | |
| Common Stock | -- | -- | -- | -- | $2.9B | |
| Other Common Equity Adj | -- | -- | -- | -- | $294K | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -- | -- | -- | -- | $982M | |
| Total Liabilities and Equity | -- | -- | -- | -- | $1.4B | |
| Cash and Short Terms | -- | -- | -- | -- | $654.6M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -$470.3M | -$203.2M | -$25.3M | |
| Depreciation & Amoritzation | -- | -- | $7.3M | $12.9M | $25.4M | |
| Stock-Based Compensation | -- | -- | $28.4M | $26M | $29.8M | |
| Change in Accounts Receivable | -- | -- | -$29.3M | -$53.3M | -$40.3M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -$434.1M | -$156.6M | $64.1M | |
| Capital Expenditures | -- | -- | $72.9M | $27.8M | $14.5M | |
| Cash Acquisitions | -- | -- | -- | -- | -$13.3M | |
| Cash From Investing | -- | -- | $150.5M | $167M | $45.7M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -$508K | -$61K | -$950K | |
| Other Financing Activities | -- | -- | -- | -$830K | -- | |
| Cash From Financing | -- | -- | $1M | $842K | $456K | |
| Beginning Cash (CF) | -- | -- | $511.1M | $228.5M | $239.7M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -$282.6M | $11.3M | $110.3M | |
| Ending Cash (CF) | -- | -- | $228.5M | $239.7M | $350M | |
| Levered Free Cash Flow | -- | -- | -$507M | -$184.4M | $49.7M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | $15.9M | $12.9M | |
| Depreciation & Amoritzation | -- | -- | -- | $5.2M | $7.3M | |
| Stock-Based Compensation | -- | -- | -- | $5.2M | $8.7M | |
| Change in Accounts Receivable | -- | -- | -- | -$12M | -$26.2M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | $72.2M | -$25.8M | |
| Capital Expenditures | -- | -- | -- | $2.2M | $4.8M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -$5.7M | $6.7M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -$29K | -- | |
| Other Financing Activities | -- | -- | -- | -- | -$843K | |
| Cash From Financing | -- | -- | -- | $179K | -$126K | |
| Beginning Cash (CF) | -- | -- | -- | $239.7M | $350M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | $66.7M | -$19.2M | |
| Ending Cash (CF) | -- | -- | -- | $306.4M | $330.8M | |
| Levered Free Cash Flow | -- | -- | -- | $70M | -$30.5M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | $5.2M | $13.9M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | $2.2M | $7M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | $15.9M | $12.9M | |
| Depreciation & Amoritzation | -- | -- | -- | $5.2M | $7.3M | |
| Stock-Based Compensation | -- | -- | -- | $5.2M | $8.7M | |
| Change in Accounts Receivable | -- | -- | -- | -$12M | -$26.2M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | $72.2M | -$25.8M | |
| Capital Expenditures | -- | -- | -- | $2.2M | $4.8M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -$5.7M | $6.7M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -$29K | -- | |
| Other Financing Activities | -- | -- | -- | -- | -$843K | |
| Cash From Financing | -- | -- | -- | $179K | -$126K | |
| Beginning Cash (CF) | -- | -- | -- | $239.7M | $350M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | $66.7M | -$19.2M | |
| Ending Cash (CF) | -- | -- | -- | $306.4M | $330.8M | |
| Levered Free Cash Flow | -- | -- | -- | $70M | -$30.5M | |
Get CHYM Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CHYM
Sector
P/E ratio
--
--
PEG ratio
--
--
P/B ratio
--
--
Price / LTM sales
--
--
Growth Metrics
CHYM
Sector
Revenue growth
--
--
Earnings growth
--
--
Revenue (5-year growth)
--
--
Earnings forecast
-$4.05
--
Profitability
CHYM
Sector
Profitability FY 2024
$1.5B
--
Return on invested capital
--
--
Return on assets
--
--
Return on equity
--
--
Earnings Date
Last Earnings Date
Jul
17
Next Earnings Date
Aug
7
Estimated Next Earnings Date
Oct
16
Balance Sheet
CHYM
Sector
Total cash
$654.6M
--
Short term investments
$368.9M
--
Total assets
$1.5B
--
Long term debt
--
--
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
